by Virtus | Mar 21, 2026 | Early-Stage Respiratory Drug Development
Preclinical feasibility studies respiratory programmes are used in early stage respiratory drug development to evaluate whether a therapeutic candidate demonstrates sufficient biological activity to justify further progression. These studies are typically designed to...
by Virtus | Mar 21, 2026 | Early-Stage Respiratory Drug Development
Outsourcing respiratory research in the UK is a common strategy for biotech and pharmaceutical companies seeking specialist expertise in preclinical respiratory studies. Respiratory drug development often requires disease-specific models, in vivo respiratory studies,...
by Virtus | Feb 4, 2026 | Early-Stage Respiratory Drug Development
Early stage respiratory drug development focuses on evaluating therapeutic feasibility, biological activity, and translational relevance before compounds progress into clinical investigation. At this stage, preclinical respiratory studies are designed to generate...
by Virtus | Feb 4, 2026 | Respiratory Preclinical Research, Uncategorized
A respiratory preclinical CRO in the UK provides specialist research services to support early stage respiratory drug development, translational research, and preclinical efficacy testing. These organisations focus on delivering disease-relevant respiratory...
by Virtus | Feb 4, 2026 | Viral & Rhinovirus Models, Uncategorized
Influenza preclinical models are widely used in respiratory preclinical research to investigate viral pathogenesis, evaluate therapeutic efficacy, and support respiratory drug development programmes. Influenza virus infection is associated with acute respiratory...
